Back
Frontier Communications Parent Vs. Rhythm Pharmaceuticals Industry Stock Comparison
Sell
48
FYBR
Frontier Communications Parent
Last Price:
35.55
Seasonality Move:
21.97%
Buy
73
RYTM
Rhythm Pharmaceuticals
Last Price:
54.70
Seasonality Move:
11.04%
Sell
48
Frontier Communications Parent (FYBR)
is a Sell
Is Frontier Communications Parent a Buy, Sell or Hold?
- The current Frontier Communications Parent [FYBR] share price is $35.35. The Score for FYBR is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- FYBR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
73
Rhythm Pharmaceuticals (RYTM)
is a Buy
Is Rhythm Pharmaceuticals a Buy, Sell or Hold?
- The current Rhythm Pharmaceuticals [RYTM] share price is $53.65. The Score for RYTM is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
- RYTM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
FYBR Stock Price Chart
What is Frontier Communications Parent's stock price today?
-
The Frontier Communications Parent share price today is $35.35
The current trend is moderately bullish and FYBR is experiencing selling pressure, which indicates risk of future bearish movement.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals's stock price today?
-
The Rhythm Pharmaceuticals share price today is $53.65
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight selling pressure.
FYBR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.07 | Buy |
| Relative Strength Index (14 RSI): | 62 | Buy |
| Chaikin Money Flow: | -3162803 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (28.08 - 35.56) | Buy |
| Bollinger Bands (100): | (24.43 - 30.91) | Buy |
RYTM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.46 | Buy |
| Relative Strength Index (14 RSI): | 67.83 | Buy |
| Chaikin Money Flow: | -159819 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (45.64 - 50.28) | Buy |
| Bollinger Bands (100): | (39.46 - 48.56) | Buy |
FYBR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 35.79 | Sell |
| 20-day SMA: | 32.64 | Buy |
| 50-day SMA: | 29.7 | Buy |
| 200-day SMA: | 25.63 | Buy |
| 8-day EMA: | 35.31 | Buy |
| 20-day EMA: | 33.36 | Buy |
| 50-day EMA: | 30.54 | Buy |
| 200-day EMA: | 26.04 | Buy |
RYTM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 50.55 | Buy |
| 20-day SMA: | 48.38 | Buy |
| 50-day SMA: | 47.86 | Buy |
| 200-day SMA: | 43.39 | Buy |
| 8-day EMA: | 50.8 | Buy |
| 20-day EMA: | 49.06 | Buy |
| 50-day EMA: | 47.17 | Buy |
| 200-day EMA: | 41.51 | Buy |
Frontier Communications Parent Earnings Growth & FYBR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.01 per share, a decrease this year of $0.67 per share, and a decrease next year of $0.00 per share.
Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.11 per share, a decrease this year of $1.34 per share, and an increase next year of $1.63 per share.
Frontier Communications Parent Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rhythm Pharmaceuticals Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||